Referred to the Committee on Natural Resources, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Original title: “HR 8658: To amend the Indian Health Care Improvement Act to modify the notification requirement for emergency contract health services for certain beneficiaries, and for other purposes.”

Referred to the House Committee on Energy and Commerce.

Original title: “HR 8657: To amend the Public Health Service Act to enhance programs for youth suicide prevention and intervention, and for other purposes.”

Read twice and referred to the Committee on Finance.

Original title: “S 400: Paid Family and Medical Leave Tax Credit Extension and Enhancement Act”

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Original title: “HR 8573: To prohibit gender transition procedures on minors, to authorize the Secretary of Health and Human Services to impose civil penalties on persons who perform gender transition procedures on minors, and for other purposes.”

Referred to the House Committee on Ways and Means.

Original title: “HR 2436: To amend the Internal Revenue Code of 1986 to treat distributions from health savings accounts for funeral expenses of the account beneficiary as qualified distributions.”

The FDA is reportedly down to a handful of final candidates to lead CBER, with a potential selection expected in the coming month or two. For now, the appointment of acting director Katherine Szarama has not allayed the industry’s concerns.

Original title: “FDA uncertainty persists as search for Prasad successor at CBER drags on”

Held at the desk.

Original title: “S 620: Veterinary Services to Improve Public Health in Rural Communities Act”

Referred to the House Committee on Agriculture.

Original title: “HR 8504: Rural Health Resilience Act of 2026”

Ordered to be Reported (Amended) by Voice Vote.

Original title: “HR 3863: VA Mental Health Outreach and Engagement Act”

Findings of research misconduct have been made against Ariel Fernandez, Ph.D. (also known as Ariel Fernandez Stigliano), former Karl F. Hasselmann Chaired Professor of Engineering, Department of Bioengineering, Rice University. Dr. Fernandez engaged in research misconduct under 42 CFR part 93 in research supported by U.S. Public Health Service (PHS) funds, specifically National Institute of General Medical Sciences (NIGMS), National Institutes of Health (NIH), grant R01 GM072614. Administrative

Original title: “Findings of Research Misconduct”

The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled World Trade Center Health Program Enrollment, Appeals & Reimbursement. This data col

Original title: “Proposed Data Collection Submitted for Public Comment and Recommendations”

Original title: “Agency Forms Undergoing Paperwork Reduction Act Review”

Original title: “Agency Forms Undergoing Paperwork Reduction Act Review”

The Agency for Toxic Substances and Disease Registry (ATSDR), within the Department of Health and Human Services (HHS), announces the opening of a docket to obtain comments on a draft of the updated Toxicological Profile for Xylene. This action is necessary as this is an opportunity for members of the public and organizations to submit comments on drafts of the profiles. The intended effect of this action is to ensure that the public can note any pertinent additional information or reports on st

Original title: “Agency for Toxic Substances and Disease Registry; Availability of Draft Toxicological Profile for Xylene”

Original title: “Agency Forms Undergoing Paperwork Reduction Act Review”

The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a continuing information collection project titled Message Testing for Tobacco Communication Activities (MTTCA). The MTTCA clearance

Original title: “Proposed Data Collection Submitted for Public Comment and Recommendations”

The Office of Community Services (OCS) is requesting a reinstatement with changes for the collection and reporting of administrative household recipient data from state Low Income Home Energy Assistance Program (LIHEAP) grant recipients. The LIHEAP Residential Energy Consumption Survey (RECS) Data Match request is completed approximately every 5 years, to support research and analysis of LIHEAP program impacts. The Office of Management and Budget (OMB) approved the original collection under #: 0

Original title: “Submission for Office of Management and Budget Review; 2024-2025 Low Income Home Energy Assistance Program (LIHEAP) Residential Energy Consumption Survey (RECS) Data Match”

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Original title: “HR 2542: Old Drugs, New Cures Act”

Placed on the Union Calendar, Calendar No. 548.

Original title: “HR 8646: Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027”

PhilHealth has expanded its coverage for rare diseases through its Z Benefits Package, which now includes at least 10 rare genetic conditions The Rare Disease Act of 2016 was designed to address many of these challenges. The law recognizes rare disease patients as persons with disabilities (PWDs), grants them access to certain benefits, and mandates the integration of rare disease management into the national healthcare system. It also calls for the creation of a national rare disease registry, improved newborn screening programs, and expanded access to treatment — including so-called “orphan drugs,” which are developed specifically for rare conditions. Advocacy groups also play a crucial role in connecting patients and families, providing support networks, and pushing for policy changes. Organizations like the Philippine Society for Orphan Disorders bring together patients, caregivers, and medical experts to amplify voices that might otherwise go unheard. This fragmentation within the healthcare system contributes to one of the most persistent challenges faced by rare disease patients: delayed diagnosis. In many cases, it can take four to eight years before a definitive diagnosis is reached. Despite their rarity, the cumulative number of patients is substantial.

Original title: “Living with rare disease: How policy shifts, medical progress bring hope to patients”